Stock Market, Market, Crash, Funds, up, Stock, Lost, decline, statistic, Crisis, Capital, BSE, NSE

As per the channel Check, APL's growth momentum is likely to remain, aided by customers shifting from refurbished steel to hot-rolled coil (HRC) structural steel tubes

APL Apollo Tubes gains over 11% in 4 days; UBS upgrades to 'Buy', raises TP

Business Standard

Nikkei slides near one month low as BOJ stays in focus

Capital Market Automatic

Chinese stocks ended with modest gains though Trump tariff fears offset upbeat Chinese economic cues and capped upside. China's Shanghai Composite index closed up 0.18% at 3,241.82. Latest data showed that China's GDP expanded 5.4% year-on-year in the fourth quarter, bettering the 4.6% growth in the third quarter. For the whole year of 2024, the economy saw an expansion of 5%, in line with the official growth target.

Chinese stocks end modestly higher amid raft of data releases

IPO rush, market

A total of 1,000 companies are expected to float initial public offerings (IPOs) in the next two financial years, the Association of Investment Bankers of India (AIBI) said on Friday.

AIBI predicts 1,000 IPOs in India over the next two financial years

Press Trust of India


The key domestic equity indices ended with modest losses on Friday, snapping a three-day winning streak. The Nifty index closed below the 23,210 mark, weighed down by weakness in the IT and banking shares.


Benchmarks retreat: IT, banking drag Nifty below 23,210

INR ends flat around 86.60 per US dollar mark

The IT major's consolidated net profit slipped 21.35% to Rs 983.2 crore in Q3 FY25 as against Rs 1,250.1 crore reported in Q3 FY24.

Tech Mahindra Q3 PAT slides 21% QoQ

The offer received bids for 49.73 crore shares as against 1.55 crore shares on offer.

Stallion India Fluorochemicals IPO subscribed 32.06 times

Shares of IDBI Bank jumped 5.67% to Rs 84.05 following the company's clarification that the strategic disinvestment process is actively underway.

IDBI Bank shares surge on disinvestment update


Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adjunctive therapy  i) in the treatment of partial-onset seizures in adults with epilepsy, ii) in the treatment of myoclonic seizures in adults with juvenile myoclonic epilepsy and iii) in the treatment of primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy. 


Caplin Point Laboratories receives USFDA approval for Levetiracetam in Sodium Chloride Injection

Companies News: Get latest company news, company results, company interviews, company financials, company analysis, company disclosure, corporate news, company announcements at Business Standard.

Company News: Company Business News, Indian Companies News, Company Analysis, Corporate Industry News

Get latest company news, company results, company interviews, company financials, company analysis, company disclosure, corporate news, company announcements at Business Standard.

Zota Health Care Ltd News